Liver News and Research

RSS

People with accelerated biological age at increased risk of COVID-19 symptom severity and mortality

Now, a new study published on the preprint server medRxiv in July 2020 discusses the explanation in terms of the biological aging markers in patients with severe disease, rather than the chronological age.

13 Jul 2020

Molecular imaging reveals inter-organ communication between the heart and kidneys after heart attack

Whole body positron emission tomography (PET) has, for the first time, illustrated the existence of inter-organ communication between the heart and kidneys via the immune system following acute myocardial infarction, or heart attack.

13 Jul 2020

Total-body dynamic PET can generate high-quality images of metastatic cancer

Results from the first study using uEXPLORER to conduct total-body dynamic positron emission tomography (PET) scans in cancer patients show that it can be used to generate high-quality images of metastatic cancer.

13 Jul 2020

Study identifies three novel broad-spectrum SARS-CoV-2 cell entry inhibitors

Researchers from the National Institutes of Health (NIH) and Cornell University in the U.S. just described several new inhibitors of human coronavirus spike proteins by screening a library of approved drugs with SARS-S and MERS-S pseudotyped particle entry assays. Their exciting findings are currently available on the bioRxiv preprint server.

13 Jul 2020

Baylor Scott & White Research Institute receives NIH award for esophageal cancer study

The incidence of esophageal adenocarcinoma has increased 8-fold over the past 50 years. This is one of the deadliest cancers, with a five-year survival rate of only 20 percent. However, the survival rate more than doubles if the cancer is identified early.

13 Jul 2020

Study shows smoking is associated with a higher likelihood of COVID-19 progression

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

13 Jul 2020

Digestive manifestations common but mild among hospitalized COVID-19 patients

A team of 121 researchers from the United States and Canada reports that while digestive manifestations seem to be common among people hospitalized with coronavirus disease 2019 (COVID-19), the majority appear to be mild and not associated with severe clinical outcomes.

12 Jul 2020

Research identifies specific brain cells that trigger sugar consumption and cravings

New research has identified the specific brain cells that control how much sugar you eat and how much you crave sweet tasting food.

12 Jul 2020

Fat cell hormone enhances therapeutic potential of MSC therapy

Mesenchymal stem cells (MSCs) have the potential to differentiate into a range of different cell types, including bone, fat, and muscle cells.

12 Jul 2020

Experts develop a simple questionnaire to raise awareness about managing liver disease

Alcohol's popularity and its central place in socializing in Australia obscures the dangers of excessive drinking and possible liver disease, Flinders University experts warn.

11 Jul 2020

Study of 17 million patients pinpoints COVID-19 mortality risk factors

Now, an analysis of 17 million people in England, the most extensive study of its kind, sheds light on certain factors that can increase a person’s chances of dying from COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

10 Jul 2020

HCV testing and treatment at federally qualified health centers can be cost-fffective

New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective.

8 Jul 2020

Scientists identify how good gut bacteria can help reduce heart disease risk

Scientists have discovered that one of the good bacteria found in the human gut has a benefit that has remained unrecognized until now: the potential to reduce the risk for heart disease.

8 Jul 2020

Scientists discover promising therapy to combat the growing epidemic of liver disease

In an effort to combat a growing worldwide epidemic of Nonalcoholic Fatty Liver Disease (NAFLD), scientists have discovered a new target and a new therapy that has shown promising results in preclinical mouse models, according to researchers at the University of Colorado Anschutz Medical Campus.

8 Jul 2020

COVID cuts a lethal path through San Quentin’s death row

The old men live in cramped spaces and breathe the same ventilated air. Many are frail, laboring with heart disease, liver and prostate cancer, tuberculosis, dementia. And now, with the coronavirus advancing through their ranks, they are falling one after the next.

8 Jul 2020

Analysis: How a COVID-19 vaccine could cost Americans dearly

Yes, of course, Americans' health is priceless, and reining in a deadly virus that has trashed the economy would be invaluable.

8 Jul 2020

China reports Dengue fever after bubonic plague threat

The actively spreading coronavirus disease (COVID-19) first emerged in China in December 2019. More than six months after, the world grapples with nearly 11.8 confirmed cases of the viral infection. Now, as China slowly starts to reboot its economy and ease lockdown restrictions, two new health issues are emerging.

8 Jul 2020

New technology can sense the presence of toxic metals in the water supply

The new platform uses cell-free synthetic biology to test for 17 contaminants, including lead, copper, pharmaceuticals and cosmetics.

7 Jul 2020

Faulty immune response to SARS-CoV-2 one of the main causes of death

A new study published on the preprint server medRxiv in July 2020 describes the organ and tissue-specific spread of the virus causing the current COVID-19 pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

7 Jul 2020

Study shows how non-alcoholic fatty liver disease causes Alzheimer's-like neuroinflammation

Research from University of South Carolina associate professor Saurabh Chatterjee's laboratory in Environmental Health Sciences, Arnold School of Public Health, and led by Ayan Mondal, a postdoctoral researcher from the same lab, has revealed the cause behind the previously established link between non-alcoholic fatty liver disease (i.e., NAFLD, recently reclassified as metabolic associated fatty liver disease or MAFLD) and neurological problems.

6 Jul 2020

Liver News and Research

People with accelerated biological age at increased risk of COVID-19 symptom severity and mortality

Molecular imaging reveals inter-organ communication between the heart and kidneys after heart attack

Total-body dynamic PET can generate high-quality images of metastatic cancer

Study identifies three novel broad-spectrum SARS-CoV-2 cell entry inhibitors

Baylor Scott & White Research Institute receives NIH award for esophageal cancer study

Study shows smoking is associated with a higher likelihood of COVID-19 progression

Digestive manifestations common but mild among hospitalized COVID-19 patients

Research identifies specific brain cells that trigger sugar consumption and cravings

Fat cell hormone enhances therapeutic potential of MSC therapy

Experts develop a simple questionnaire to raise awareness about managing liver disease

Study of 17 million patients pinpoints COVID-19 mortality risk factors

HCV testing and treatment at federally qualified health centers can be cost-fffective

Scientists identify how good gut bacteria can help reduce heart disease risk

Scientists discover promising therapy to combat the growing epidemic of liver disease

COVID cuts a lethal path through San Quentin’s death row

Analysis: How a COVID-19 vaccine could cost Americans dearly

China reports Dengue fever after bubonic plague threat

New technology can sense the presence of toxic metals in the water supply

Faulty immune response to SARS-CoV-2 one of the main causes of death

Study shows how non-alcoholic fatty liver disease causes Alzheimer's-like neuroinflammation

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News